Follow
Michael T. Boyne II
Michael T. Boyne II
Co-founder and Principal, CatalystBio
Verified email at catalystbio.co
Title
Cited by
Cited by
Year
Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach
SA Carr, SE Abbatiello, BL Ackermann, C Borchers, B Domon, ...
Molecular & Cellular Proteomics 13 (3), 907-917, 2014
5522014
Abacavir induces loading of novel self-peptides into HLA-B* 57: 01: an autoimmune model for HLA-associated drug hypersensitivity
MA Norcross, S Luo, L Lu, MT Boyne, M Gomarteli, AD Rennels, ...
AIDS 26 (11), F21-F29, 2012
2712012
Precise characterization of human histones in the H2A gene family by top down mass spectrometry
MT Boyne II, JJ Pesavento, CA Mizzen, NL Kelleher
Journal of proteome research 5 (2), 248-253, 2006
1752006
Biosynthesis of pipecolic acid by RapL, a lysine cyclodeaminase encoded in the rapamycin gene cluster
GJ Gatto, MT Boyne, NL Kelleher, CT Walsh
Journal of the American Chemical Society 128 (11), 3838-3847, 2006
1592006
Top-down proteomics on a chromatographic time scale using linear ion trap Fourier transform hybrid mass spectrometers
BA Parks, L Jiang, PM Thomas, CD Wenger, MJ Roth, MT Boyne, ...
Analytical chemistry 79 (21), 7984-7991, 2007
1522007
Hydroxymalonyl-acyl carrier protein (ACP) and aminomalonyl-ACP are two additional type I polyketide synthase extender units
YA Chan, MT Boyne II, AM Podevels, AK Klimowicz, J Handelsman, ...
Proceedings of the National Academy of Sciences 103 (39), 14349-14354, 2006
150*2006
Precise and parallel characterization of coding polymorphisms, alternative splicing, and modifications in human proteins by mass spectrometry
MJ Roth, AJ Forbes, MT Boyne, YB Kim, DE Robinson, NL Kelleher
Molecular & Cellular Proteomics 4 (7), 1002-1008, 2005
122*2005
A retrospective evaluation of the use of mass spectrometry in FDA biologics license applications
S Rogstad, A Faustino, A Ruth, D Keire, M Boyne, J Park
Journal of the American Society for Mass Spectrometry 28 (5), 786-794, 2016
1082016
TAK-101 nanoparticles induce gluten-specific tolerance in celiac disease: a randomized, double-blind, placebo-controlled study
CP Kelly, JA Murray, DA Leffler, DR Getts, AC Bledsoe, G Smithson, ...
Gastroenterology 161 (1), 66-80. e8, 2021
962021
Post-translational structural modifications of immunoglobulin G and their effect on biological activity
LK Hmiel, KA Brorson, MT Boyne
Analytical and bioanalytical chemistry 407, 79-94, 2015
882015
Tandem mass spectrometry with ultrahigh mass accuracy clarifies peptide identification by database retrieval
MT Boyne, BA Garcia, M Li, L Zamdborg, CD Wenger, S Babai, ...
Journal of proteome research 8 (1), 374-379, 2009
732009
“Proteotyping”: population proteomics of human leukocytes using top down mass spectrometry
MJ Roth, BA Parks, JT Ferguson, MT Boyne, NL Kelleher
Analytical chemistry 80 (8), 2857-2866, 2008
722008
The role of mass spectrometry in the characterization of biologic protein products
D Rathore, A Faustino, J Schiel, E Pang, M Boyne, S Rogstad
Expert review of proteomics 15 (5), 431-449, 2018
652018
Determination of the NISTmAb primary structure
T Formolo, M Ly, M Levy, L Kilpatrick, S Lute, K Phinney, L Marzilli, ...
State-of-the-art and emerging technologies for therapeutic monoclonal …, 2015
632015
Structural comparison of two anti-CD20 monoclonal antibody drug products using middle-down mass spectrometry
B Wang, AC Gucinski, DA Keire, LF Buhse, MT Boyne II
Analyst 138 (10), 3058-3065, 2013
582013
Direct approach for qualitative and quantitative characterization of glycoproteins using tandem mass tags and an LTQ Orbitrap XL electron transfer dissociation hybrid mass …
H Ye, MT Boyne, LF Buhse, J Hill
Analytical chemistry 85 (3), 1531-1539, 2013
562013
Characterization of the aminocarboxycyclopropane-forming enzyme CmaC
WL Kelly, MT Boyne, E Yeh, DA Vosburg, DP Galonić, NL Kelleher, ...
Biochemistry 46 (2), 359-368, 2007
532007
Characterization of currently marketed heparin products: Analysis of heparin digests by RPIP-UHPLC–QTOF-MS
B Wang, LF Buhse, A Al-Hakim, MTB Ii, DA Keire
Journal of pharmaceutical and biomedical analysis 67, 42-50, 2012
462012
Bioreactor process parameter screening utilizing a Plackett-Burman design for a model monoclonal antibody
CD Agarabi, JE Schiel, SC Lute, BK Chavez, MT Boyne II, KA Brorson, ...
Journal of pharmaceutical sciences 104 (6), 1919-1928, 2015
452015
Quality assessment of US marketplace vancomycin for injection products using high-resolution liquid chromatography-mass spectrometry and potency assays
ME Hadwiger, CD Sommers, DJ Mans, V Patel, MT Boyne
Antimicrobial agents and chemotherapy 56 (6), 2824-2830, 2012
452012
The system can't perform the operation now. Try again later.
Articles 1–20